AML cells also demonstrate a global reduction in H3 acetylation, partially attributable to oncogenic fusion proteins (e.g., PML-RARα, AML-ETO), aberrantly recruiting HDACs. This evidence concerns the gene RARA and acute myeloid leukemia.